SHILPAMED Shilpa Medicare Ltd US FDA Inspections Announcement 2024 - Clinical Trial Approval Shilpa Medicare Ltd has received approval from the Indian regulatory authority to conduct Phase III clinical trials for its Recombinant Human Albumin (rHA) 20%, making it the first Indian company to do so..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Shilpa Medicare Ltd